icotine delivery in venous blood during the use of tobacco heating devices within the acute phase. - Nicotide Heat

MU Klinikum München - Klinik für Psychiatrie und Psychotherapie0 个研究点目标入组 15 人开始时间: 2021年8月30日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•General inclusion criteria:
•- Subjects between 18 and 55 years of age
•- 12-hour abstinence (tobacco and nicotine use).
•- CO < 5ppm; measurement in expiratory air using micro-smokerlyzer (Bedfont Scientific Ltd).
•- Ability to state an informed consent
•Specific inclusion criteria
•- experienced user of a tobacco heating device (e.g., IQOS, glo™) for at least 3 months (at least 10 tobacco sticks per day)
•- Occasional use of conventional tobacco cigarettes for at least 3 months (max. 20 cigarettes per week)

•- Patients under 18 years of age or over 55 years of age
•- acute psychiatric illness according to ICD-10/DSM IV
•- other severe psychiatric illnesses
•- acute suicidal tendencies
•- existing pregnancy
•- drug, medication, or alcohol abuse at the time of the study
•- current malignant cancer during the last 5 years
•- severe internal diseases, especially cardiovascular diseases, such as manifest arterial hypertension, severe heart disease (DCM, history of myocardial infarction), cardiac pacemaker, respiratory insufficiency (e.g. asthma, COPD)
•- severe active infectious diseases
•- CO >5 ppm in the expirium
•- Other circumstances that, in the opinion of the study physician, militate against the patient's participation in this study.

发起方

MU Klinikum München - Klinik für Psychiatrie und Psychotherapie